CT

Current Treatment Options In Oncology

Current Treatment Options in Oncology offers in-depth review articles contributed by international experts on significant developments in oncology, emphasizing recently published papers of major importance and current and emerging approaches to cancer treatment.

Looking to publish in Current Treatment Options In Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 4.7
Quartile Q1
Open Access Type Hybrid
ISSN 1527-2729
eISSN 1534-6277
Invitation Only Yes
Cost Range Open access APC: £3290.00 GBP / $5190.00 USD / €4090.00 EUR; subscription publishing: no APC charges apply.

Submission Instructions

Current Treatment Options In Oncology is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:

Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required in the form of an Opinion Statement. The Opinion Statement must be 200 to 300 words. The abstract must be unstructured as an Opinion Statement. The abstract must include an "Opinion Statement" that summarizes how the author would treat the disease and presents the author's opinion on the treatment options discussed in the article body.
Manuscript Reviews must include a statement of author contributions indicating who conceived the article, performed the literature search and data analysis, and drafted and/or critically revised the work, and they also require a disclosure statement.
References References must be cited in the text using numbers in square brackets. The reference list must contain only cited published or accepted works, be numbered consecutively, include full DOI links when available, and use standard journal title abbreviations or the full title if unsure.
Figures & Tables Figures should be submitted within the body of the text and submitted separately only if file size causes upload problems. The Opinion Statement must not include figure, table, or reference callouts.
Reformat to Current Treatment Options In Oncology using Livewrite Premium

Invited Commentaries

Cover Letter Cover Letter requirements are not specified.
Abstract An Opinion Statement of 200 to 300 words is required in place of a standard abstract. Opinion Statement must be 200 to 300 words. The abstract-equivalent must be an unstructured Opinion Statement. The manuscript must include an "Opinion Statement" that summarizes how the author would treat the disease and presents the author's opinion on the treatment options discussed in the article.
Manuscript The manuscript must include an Opinion Statement, a statement of responsibility specifying each author's contribution, and a "Statements and Declarations" section including a Competing Interests statement, with any use of a large language model documented in the Methods section or another suitable section if no Methods section is available.
References Citations must be numbered in square brackets. The reference list must contain only cited published or accepted works, numbered consecutively, with journal titles abbreviated according to ISSN standards or given in full if unsure, and DOI links included when available.
Figures & Tables Figures should be submitted within the body of the text and large figures submitted separately only if file size causes upload problems. Tables and figures must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by captions, with previously published material credited in the caption.
Reformat to Current Treatment Options In Oncology using Livewrite Premium

Recent Publications

Beyond CDK4/6 Inhibition: Current Strategies in Hormone Receptor-Positive Metastatic Breast Cancer

Bulent Cetin, Dilek Erdem, Irem Karaman, Ozge Gumusay

10.1007/s11864-026-01391-3
View Publication

The Current Cardio-Oncology Landscape Across Australia

Daniel H. Chen, Lloyd Butel-Simoes, Mitchum Bower, Mark T. Nolan, Sanjeev S. Kumar, Trent D. Williams, Bogda Koczwara, Philippa Ell, Joshua D. Bennetts, Gayathri R. Nair, John Lee, Satish Ramkumar, Doan T. M. Ngo, Aaron L. Sverdlov

10.1007/s11864-026-01390-4
View Publication

Imaging Strategies and Research Advances in Gastrointestinal Stromal Tumors

Dongxiao Yang, Guanghui Yu

10.1007/s11864-026-01389-x
View Publication

Advances in Pharmacologic- and Non-pharmacologic Interventions for Cancer Pain: A Narrative Review

Shulin Wang, Jingyu Yao, Qiuli Wang, Wei Yang, Jun Zhao

10.1007/s11864-026-01393-1
View Publication

Addressing Unmet Needs in the Management of Small Cell Lung Cancer: Treatment of Brain Metastases, Quality of Life, and the Role of Real-World Evidence

Yunfei Dai, Jing Fei

10.1007/s11864-026-01392-2
View Publication

Frequently asked questions

How long does it take to publish?

The article will be published online after receipt of the corrected proofs.

Reformat to Current Treatment Options In Oncology using Livewrite Premium

Is a cover letter required?

A submission letter is used when suggesting reviewers and for mentioning unpublished material included in the manuscript. A cover letter is required to explain reuse of material and mention unpublished material included in the manuscript.

Reformat to Current Treatment Options In Oncology using Livewrite Premium

What are the publication costs?

Open access APC: £3290.00 GBP / $5190.00 USD / €4090.00 EUR. Subscription publishing is available with no APC charges.

Reformat to Current Treatment Options In Oncology using Livewrite Premium

Research Topics

Lymphoma Diagnosis and Treatment Sarcoma Diagnosis and Treatment Lung Cancer Research Studies Lung Cancer Treatments and Mutations Glioma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Neuroendocrine Tumor Research Advances Chronic Lymphocytic Leukemia Research Colorectal Cancer Treatments and Studies Cancer Genomics and Diagnostics Brain Metastases and Treatment Ovarian cancer diagnosis and treatment Gastric Cancer Management and Outcomes Head and Neck Cancer Studies Neuroblastoma Research and Treatments HER2/EGFR in Cancer Research Acute Myeloid Leukemia Research Endometrial and Cervical Cancer Treatments Breast Cancer Treatment Studies Lung Cancer Diagnosis and Treatment Cardiac tumors and thrombi Vascular Tumors and Angiosarcomas Prostate Cancer Treatment and Research Immunotherapy and Immune Responses

Related Journals

CA
Current Addiction Reports Springer Science+Business Media
CB
Cancer Biology & Therapy Taylor & Francis
JO
Journal Of Nutrition Health & Aging Springer Science+Business Media
NR
Nature Reviews Cancer NATURE PORTFOLIO
RM
Radiologia Medica Springer Science+Business Media
TO
Translational Oncology Elsevier BV